Stock ZIM ZIMMER BIOMET HOLDINGS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Ratings Zimmer Biomet Holdings, Inc. Deutsche Boerse AG

Equities

ZIM

US98956P1021

Market Closed - Deutsche Boerse AG
Other stock markets
 02:00:08 2024-07-12 am EDT 		After market 04:00:02 pm
99.02 EUR +0.92% Intraday chart for Zimmer Biomet Holdings, Inc. 99.69 +0.68%
Jul. 11 Citigroup Adjusts Price Target on Zimmer Biomet to $120 From $134 MT
Jul. 11 Citigroup Adjusts Price Target on Zimmer Biomet to $134 From $120 MT

Strengths

  • The company's EBITDA/Sales ratio is relatively high and results in high margins before depreciation, amortization and taxes.
  • The group's high margin levels account for strong profits.
  • The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.

Weaknesses

  • The company's enterprise value to sales, at 3.43 times its current sales, is high.
  • The firm pays small or no dividend to shareholders. For that reason, it is not a yield company.
  • For the last four months, EPS estimates made by Standard & Poor's analysts have been revised downwards.

Ratings chart - Surperformance

Sector: Medical Equipment, Supplies & Distribution

1st Jan change Capi. Investor Rating ESG Refinitiv
ZIMMER BIOMET HOLDINGS, INC. Stock Zimmer Biomet Holdings, Inc.
-9.78% 22.26B -
ABBOTT LABORATORIES Stock Abbott Laboratories
-5.31% 181B
C+
MEDTRONIC PLC Stock Medtronic plc
-5.38% 100B
C
BECTON, DICKINSON AND COMPANY Stock Becton, Dickinson and Company
-6.04% 65.01B
A
HOYA CORPORATION Stock Hoya Corporation
+16.45% 45.75B
B+
DEXCOM, INC. Stock DexCom, Inc.
-8.08% 44.8B
B-
CENCORA, INC. Stock Cencora, Inc.
+8.38% 43.72B
B-
METTLER-TOLEDO INTERNATIONAL, INC. Stock Mettler-Toledo International, Inc.
+12.06% 29.01B
B
TERUMO CORPORATION Stock Terumo Corporation
+17.98% 26.03B
A-
WEST PHARMACEUTICAL SERVICES, INC. Stock West Pharmaceutical Services, Inc.
-8.28% 24.28B
A-
Investor Rating
Trading Rating
ESG Refinitiv
-

Financials

Sales growth
Earnings Growth
EBITDA / Sales
Profitability
Finances

Valuation

P/E ratio
EV / Sales
Price to Book
Price to Free Cash Flow
Yield

Momentum

1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision

Consensus

Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
12m Revision of opinion

Business Predictability

Analyst Coverage
Divergence of Estimates
Divergence of analysts' opinions
Divergence of Target Price
Earnings quality

Technical analysis

ST Timing
MT Timing
LT Timing
RSI
Bollinger Spread
Unusual volumes
  1. Stock Market
  2. Equities
  3. ZBH Stock
  4. ZIM Stock
  5. Ratings Zimmer Biomet Holdings, Inc.